BOSTON--(BUSINESS WIRE)--Joslin Diabetes Center announces a newly signed collaboration with Sanofi (EURONEXT: SAN and NYSE: SNY) which extends their ongoing collaboration in exploring novel targets for treatment of diabetes.
![]()
↧